Liver Cancer Clinical Trials in San Diego, CA

23 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients	—	University of California, San Diego	<1 mi
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma	Phase 3	Children's Oncology Group	<1 mi
Cryoablation and Arterial Infusion of SD-101 in Combination with Durvalumab and Tremelimumab	Phase 1	University of California, San Diego	<1 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI	N/A	VA Office of Research and Development	<1 mi
DESTINY-PANTUMOUR04	—	AstraZeneca	<1 mi
Early Detection of Advanced Adenomas and Colorectal Cancer	—	City of Hope Medical Center	<1 mi
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)	Phase 1/2	Hoffmann-La Roche	<1 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	<1 mi
Observational Study Protocol: LIVER-R	—	AstraZeneca	2 mi
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor	Phase 1/2	Eisai Inc.	11 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma	Phase 1	Alnylam Pharmaceuticals	11 mi
To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients	N/A	University of California, San Diego	11 mi
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma	Phase 1/2	Tvardi Therapeutics, Incorporated	11 mi
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3	—	Replimune Inc.	11 mi
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer	—	National Cancer Institute (NCI)	11 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis	Phase 2	Genentech, Inc.	11 mi
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies	Phase 1	BioEclipse Therapeutics	11 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	11 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	11 mi
CapTemY90 for Grade 2/3 NET Liver Metastases	Phase 2	Abramson Cancer Center at Penn Medicine	11 mi
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours	Phase 1/2	AstraZeneca	11 mi
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma	Phase 1/2	Abivax S.A.	11 mi
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC	Phase 2	Replimune Inc.	11 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.